Headquartered within steps of the USPTO with an affiliate office in Tokyo, Oblon is one of the largest law firms in the United States focused exclusively on intellectual property law.
1968
Norman Oblon with Stanley Fisher and Marvin Spivak launched what was to become Oblon, McClelland, Maier & Neustadt, LLP, one of the nation's leading full-service intellectual property law firms.
Outside the US, we service companies based in Japan, France, Germany, Italy, Saudi Arabia, and farther corners of the world. Our culturally aware attorneys speak many languages, including Japanese, French, German, Mandarin, Korean, Russian, Arabic, Farsi, Chinese.
Oblon's professionals provide industry-leading IP legal services to many of the world's most admired innovators and brands.
From the minute you walk through our doors, you'll become a valuable part of a team that fosters a culture of innovation, client service and collegiality.
The United States Patent and Trademark Office (USPTO) issued final rules implementing the inventor's oath or declaration provisions of the America Invents Act (AIA) on August 14, 2012.
Les Nouvelles - Licensing Executives Society International (LESI)
A recent article authored by Charles Gholz and John Presper published in Intellectual property Today.
IP Today
FOR IMMEDIATE RELEASE The U.S. Court of Appeals for the Federal Circuit issued a precedential decision on September 11th relating to the test of obviousness for design patents in High Point Design v. Buyer's Direct (No. 2012-1455). Oblon Spivak, counsel for Buyer's Direct (BDI), succeeded in obtaining a reversal of the district court's summary of judgment of invalidity of Buyer's Direct design patent (U.S. Design Patent No. D598,183). In addition, the district court's dismissal of Buyer's Direct trade dress claim was vacated.
For Immediate Release Alexandria, VA – Oblon, Spivak, McClelland, Maier & Neustadt, L.L.P. is pleased to announce that seven partners have been named to the 2014 edition of The Best Lawyers in America. Charles L. Gholz, Gerald J. Mossinghoff, Arthur I. Neustadt and Norman F. Oblon are all recognized as among the best in Intellectual Property Law or Litigation. Best Lawyers is widely regarded as the preeminent referral source to the legal profession in the United States.
The Best Lawyers in America, U.S. News and World Report
Oblon Spivak is pleased to announce that its Patent Prosecution practice and individuals from the firm's ITC and Post-Grant practices have received top national rankings in the 2013 edition of IAM Patent 1000: The World's Leading Patent Practitioners.
Oblon Spivak is proud to announce that a firm partner has been named "IP Stars" by Managing Intellectual Property's IP Handbook.
Managing Intellectual Property
Arthur Neustadt is quoted in Law360's recent article regarding the U.S. Supreme Court's decision to hear Medtronic Inc.'s appeal of a Federal Circuit decision holding that licensee Medtronic bore the burden of proof to show that its products are not covered by the licensed patents.
Law360, New York (May 20, 2013)
In MemoriamGregory J. Maier 1943 – 2013 It is with great sorrow that we inform you of the passing of one of our firm's founders, Gregory (Greg) J. Maier, who passed away peacefully, May 23, 2013.
On Friday May 10, 2013, the Federal Circuit issued an en banc decision in the CLS Bank v. Alice Corp. case. In this case, the Federal Circuit considered the scope of patentable subject matter (35 U.S.C. § 101) for computer-related inventions. Unfortunately, the Federal Circuit was unable to reach a majority consensus on the proper test to use for making such determinations. As a result, it is likely that the Supreme Court will take this case and provide guidance on this topic. In the meantime, claiming strategies should continue to include computer-tying limitations where possible, but dramatic changes to prosecution strategies should be avoided until such time as the Supreme Court speaks on the issue or we receive clear guidance from the Federal Circuit. Also, given the confusion surrounding § 101, it seems wise to raise § 101 as a defense in patent litigation or as a challenge in post-grant proceedings where appropriate.